Narwhal Capital Management Thermo Fisher Scientific Inc. Transaction History

Narwhal Capital Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	SELL	$498.29 - $574.41 $1.25 Million - $1.44 Million	-2,499 Reduced 61.22%	1,583 $801,000
Q2 2023 Aug 02, 2023	BUY	$508.46 - $591.13 $1.07 Million - $1.24 Million	2,106 Added 106.58%	4,082 $2.13 Million
Q1 2023 May 01, 2023	SELL	$535.0 - $604.82 $109,140 - $123,383	-204 Reduced 9.36%	1,976 $1.14 Million
Q4 2022 Jan 30, 2023	SELL	$484.71 - $571.37 $375,165 - $442,240	-774 Reduced 26.2%	2,180 $1.2 Million
Q3 2022 Oct 31, 2022	BUY	$507.19 - $604.49 $404,737 - $482,383	798 Added 37.01%	2,954 $1.5 Million
Q2 2022 Aug 01, 2022	SELL	$500.9 - $612.21 $467,339 - $571,191	-933 Reduced 30.2%	2,156 $1.17 Million
Q1 2022 Apr 26, 2022	BUY	$524.0 - $644.92 $1.09 Million - $1.34 Million	2,075 Added 204.64%	3,089 $1.83 Million
Q4 2021 Jan 26, 2022	BUY	$569.0 - $667.24 $576,966 - $676,581	1,014 New	1,014 $677,000

2,892

342M

2.09M

2.73M

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $209B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

Get notified when there are updates to the investment portfolio of Narwhal Capital Management, based on Form 13F filings with the SEC.

Stay updated on Narwhal Capital Management with notifications on news.